medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2023, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2023; 21 (1)

COVID-19 pandemic: telemedicine and teledermatology growth
Part I: Impact of COVID-19, historical origins of telemedicine, medical strategies and interactions, technical and technological concepts

Seijo CJA, Ramos GJA, Valdés VJJ, Meneses DLE, Ángeles AJL

Language: Spanish
References: 53
Page: 45-58
PDF size: 344.11 Kb.


ABSTRACT

Currently, telemedicine is known as the series of strategies that uses telecommunications technology to offer remote health care services. Recent technological advances have increased the ability of clinicians to apply it.
On the other hand, dermatology is ideally suited for this care model because it relies on visual elements, captured by digital imaging. The pandemic outbreak by the contagious SARS-COV-2 virus, raised an impulse to teledermatology. In the first part of this paper, we review the impact and historical origins of COVID-19 pandemic in telemedicine and teledermatology, the strategies in patient care and modalities of interactions, technological requirements and the state of the art in telemedicine in dermatology.


REFERENCES

  1. Chen Y, Pradhan S y Xue S, What are we doing in the dermatologyoutpatient department amidst the raging of the 2019 novel coronavirus?,J Am Acad Dermatol 2020; 82(4):1034.

  2. Oldenburg R y Marsch A, Optimizing teledermatology visits for dermatologyresident education during the covid-19 pandemic, J AmAcad Dermatol 2020; 82:e229. doi: 10.1016/j.jaad.2020.03.097.

  3. World Health Organization (who), who Director-General’s openingremarks at the media briefing on covid-19: 11 March 2020. Disponibleen: http://www.who.int/director-general/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020>.

  4. https://www.who.int/emergencies/diseases/novel-coronavirus-2019

  5. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S y Schünemann HJ, Physicaldistancing, face masks, and eye protection to prevent personto-person transmission of sars-cov-2 and covid-19: a systematicreview and meta-analysis, The Lancet 2020. Disponible en: https://doi.org/10.1016/S0140-6736(20)31142-9.

  6. Kashlan R, Lyons AB, Hivnor C y Ozog DM, N95 respirators for dermatologicsurgery and laser procedures during covid-19 and beyond,Dermatologic Surgery 2020; 46:1441-2. JOSÉ A. SEIJO CORTÉS Y COLS. COVID 19, TELEMEDICINA Y TELEDERMATOLOGÍA

  7. Price KN, Thiede R, Shi VY y Curiel-Lewandrowski C, Strategic dermatologyclinical operations during covid-19 pandemic, J Am AcadDermatol. 2020; 82(6):e207-9. doi: 10.1016/j.jaad.2020.03.089

  8. Kisely S et al., Occurrence, prevention, and management of the psychologicaleffects of emerging virus outbreaks on healthcare workers:rapid review and meta-analysis, bmj 2020. doi: 10.1136/bmj.m1642:10.1136/bmj.m1642.

  9. Kwatra SG, Sweren RJ y Grossberg AL, Dermatology practices as vectorsfor covid-19 transmission: a call for immediate cessation of nonemergentdermatology visits, J Am Acad Dermatol 2020; 82:e179-80.doi: 10.1016/j.jaad.2020.03.037.

  10. Galván Casas C et al., Classification of the cutaneous manifestationsof covid-19: a rapid prospective nationwide consensus study in Spainwith 375 cases, Br J Dermatol 2020; 183:71-77.

  11. Bernocchi P et al., Healthcare continuity from hospital to territory inLombardy: telemaco Project, Am J Manag Care 2012; 18:e101-8.

  12. Kennedy J et al., Dermatologist perceptions of teledermatology implementationand future use after covid-19: demographics, barriers, andinsights, jama Dermatology 2021; 157:595-7.

  13. US Centers for Disease Control and Prevention, Using telehealth toexpand access to essential health services during the covid-19 pandemic.Updated 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/telehealth.html.

  14. Perkins S, Cohen JM, Nelson CA y Bunick CG, Teledermatologyin the era of covid-19: experience of an academic department ofdermatology, J Am Acad Dermatol 2020; 83:e43-4. doi: 10.1016/j.jaad.2020.04.048.

  15. García-Lozano JA, Garza-Rodríguez V, Cuéllar-Barboza A, Vázquez-Martínez O y Ocampo-Candiani J, Dermatologic surgery training duringthe covid-19 era, J Eur Acad Dermatol Venerol 2020; 34:e370-2.14.

  16. Majul R, De la telemedicina a la telepresencia, Rev Soc Arg Diab 2020;54:32.

  17. Belvís R, Santos-Lasaosa S, Irimia P et al., Aplicación de la telemedicinaen la asistencia a pacientes con cefaleas: situación actual y recomendacionesdel Grupo de Estudio de Cefaleas de la Sociedad Españolade Neurología, Neurología. Disponible en: https://doi.org/10.1016/j.nrl.2021.01.018.

  18. Wooton R, Recent advances. Telemedicine, bmj 2001; 323:557-60.

  19. Coates SJ, Kvedar J y Granstein RD, Teledermatology: from historialperspective to emerging techniques of the modern era. Part i:History, rationale, and current practice, J Am Acad Dermatol 2015;72:563-74.

  20. Vidaram DA, The history of teledermatology in the Department ofDefense, Dermatol Clin 2001; 17:113-23.

  21. Perednia DA y Brown NA, Teledermatology: one application of telemedicine,Bull Med Libr Assoc 1995; 83:42-7.

  22. Chuchuvara N et al., The growth of teledermatology: expanding toreach underserved, J Am Acad Dermatol 2020; 82:1025-33.

  23. Perednia DA, What dermatologists should know about digital imaging,J Am Acad Dermatol 1991; 25:89-108.

  24. Brewer AC et al., Mobile applications in dermatology, jama Dermatol2011; 149:1300-4.

  25. Sandoval-Gutiérrez JL, Monraz-Pérez S, Benítez-Pérez RE y Mireles-Cabodevila E, Utilidad de la telemedicina en las enfermedades respiratorias,Neumol Cir Torax 2020; 79:12-6.

  26. Lee I, Kovarik C, Tejasvi T, Pizarro M y Lipoff JB, Telehealth: helpingyour patients and practice survive and thrive during the covid-19crisis with rapid quality implementation, J Am Acad Dermatol 2020;82(5):1213-4. doi: 10. 1016/j.jaad.2020.03.052.

  27. Weinstein RS, Krupinski EA y Doarn CR, Clinical examination componentof telemedicine, telehealth, mhealth, and connected healthmedical practices, Med Clin N Am 2018; 102:533-44.

  28. American Telemedicine Asociation, Telemedicine defined. Disponibleen: http:// www.americantelemed.org/about-telemedicine/what-istele-medicine.

  29. Alonso C, Salerni G y Fernández Bussy R, Teledermatología: aplicacionesactuales y futuras, Dermatol Argent 2017; 23:29-33.

  30. Sethman A, Telemedicina y teledermatología (editorial), DermatologíaArgentina 2017; 23:1-2.

  31. Wang RF et al., Improved patient access and outcomes with the integrationon an eConsult program (teledermatology) within a largeacademic center, J Am Acad Dermatol 2020; 83:1633-8.

  32. Pathipati AS, Lee L y Armstrong AW, Health-care delivery methodsin teledermatology: consultative, triage and direct-care models, JTelemed Telecar 2011; 17:214-6.

  33. Binder B, Hofmann-Wellenhof R, Salmhofer W, Okcu A, Helmut KerlH y Soyer HP, Teledermatological monitoring of leg ulcers in cooperationwith home care nurses, Arch Dermatol 2007; 143:1511-4.

  34. 5g y 4g ¿Cuál es la diferencia? Disponible en: https://www.thalesgroup.com/es/el-mundo-digital-identity-and-security/mobile/magazine/5g-4g-cual-es-diferencia.

  35. Giordano V, Koch H, Godoy-Santos A, Dias Belangero W, EstevesSantos Pires R y Labronici P, WhatsApp messenger as an adjunctivetool for telemedicine: an overview, Interact J Med Res 2017; 6(2):e11.doi: 10.2196/ijmr.6214.

  36. Duong TA et al., Did WhatsApp reveal a new cutaneous covid-19manifestation?, Journal of the European Academy of Dermatology and Venereology2020; 34:e348-50.

  37. Lan J, Song Z, Miao X et al., Skin damage among healthcare workersmanaging coronavirus disease-2019, J Am Acad Dermatol 2020; 82:1215-6.

  38. Flaten HK, St Claire C, Schlager E, Dunnick CA y Dellavalle RP, Growthof mobile applications in dermatology 2017 update, Dermatol Online J2018; 24(2). Disponible en: https://doi.org/13030/ qt3hs7n9z6.

  39. McKoy K, Antoniotti NM, Armstrong A et al., Practice guidelines forteledermatology, Telemed J E Health 2016; 22(12):981-90.

  40. Harvey JB, Valenta S, Simpson K, Lyles M y McElligott J, Utilizationof outpatient telehealth services in parity and nonparity states 2010-2015, Telemed J E Health 2019; 25:132-6. doi:10.1089/tmj.2017.0265.

  41. Gerard P, Kapadia N, Acharya J, Chang P y Lefkovitz Z, Cybersecurityin radiology: access of public hot spots and public Wi-Fi and preventionof cybercrimes and hipaa violations, ajr Am J Roentgenol, 2013;201(6):1186-9. doi: 10.2214/AJR.12.9651.

  42. Satou GM, Rheunan H, Alverson D et al., Telemedicine in pediatriccardiology: a scientific statement from the American Heart Association,Circulation 2017; 135:e648-78.

  43. Biagio L, Swanepoel DW, Adeyemo A et al., Asynchronous video-otoscopywith a telehealth facilitator, Telemed J E Health 2013; 19(4):252-8.

  44. Lundberg T, De Jager LB y Laurent C, Diagnostic accuracy of a generalpractitioner with video-otoscopy collected by a health care facilitatorcompared to traditional otoscopy, Int J Pediatr Otorhinolaryngol 2017;99:49-53.

  45. Morejón Barragán AL et al., Implementación del retinógrafo no midriáticoy de un tipo de telemedicina para la pesquisa de retinopatíadiabética, Revista de la Sociedad Argentina de Diabetes 2020; 54(3Sup):133.

  46. Rathi S, Tsui E, Mehta N et al., The current state of teleophthalmologyin the United States, Ophthalmology 2017; 124(12):1729-34.

  47. Fierson WM y Capone A Jr, Telemedicine for evaluation of retinopathyof prematurity, Pediatrics 2015; 135(1):e238-54.

  48. Jover R, Clofent J, De Vera F et al., Recomendaciones de la SociedadValenciana de Patología Digestiva sobre uso de consultas no presencialesy telemedicina, Gastroenterología y Hepatología. Disponible en:https://doi.org/10.1016/j.gastrohep.2021.04.009.

  49. Ohta H y Kawashima M, Technical feasibility of patient-friendlyscreening and treatment of digestive disease by remote control roboticcapsule endoscopes via the internet, Conf Proc ieee Eng Med BiolSoc 2014; 2014:7001-4.

  50. Sosa L et al., Telemedicina en tiempos de covid-19, Rev Soc Arg Diab2020; 54:123.

  51. Gosenbacher LA, ¿Cómo adaptamos la atención hospitalaria en pacientescon hiperglucemia y covid-19?, Rev Soc Arg Diab 2021; 55(2):35-6.

  52. Castillo J et al., Utilidad de las herramientas virtuales y la telemedicinaen el manejo de la diabetes gestacional durante la pandemia decovid-19 en la Ciudad Autónoma de Buenos Aires, Rev Soc Arg Diab2020; 54:161-6.

  53. Kane CK y Gillis, The use of telemedicine by physicians: still the exceptionrather than the rule, Health Aff 2018; 37:1923-30.




2020     |     www.medigraphic.com